FindMyKOL
Clinical trialNCT02995395CompletedObservational

Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)

NCT02995395 is an observational study sponsored by Mayo Clinic. As of 21 Nov 2026, it is completed. It studies Eosinophilic Esophagitis and Healthy. The registry lists an enrollment of 28 participants at 1 site in 1 country. The registry lists a start date of 1 Oct 2017 and a primary completion date of 31 Aug 2019.

SponsorMayo Clinic →Enrollment28Eosinophilic EsophagitisHealthy
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02995395
FieldValue
Registry IDNCT02995395
StatusCompleted
Study typeObservational study
Lead sponsorMayo Clinic
Enrollment28
Registered sites1
Countries1
ConditionsEosinophilic Esophagitis and Healthy
Start1 Oct 2017
Primary completion31 Aug 2019
Study completion31 Aug 2020
Last update posted3 Feb 2021

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate the role the balloon mucosal impedance may have in diagnosing and monitoring the patients with Eosinophilic Esophagitis. We will compare the results of the balloon mucosal impedance in patients with Eosinophilic esophagitis and controls.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Minnesota, United States1 site
  • Mayo Clinic in Rochester

    Rochester

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesota: 1 siteMN1WisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02995395

Each answer restates registry values shown on this page.

What is NCT02995395?

NCT02995395 is an observational study sponsored by Mayo Clinic. It studies Eosinophilic Esophagitis and Healthy.

Who leads NCT02995395?

The registry names David A Katzka (principal investigator, Mayo Clinic) as the overall official.

Where does NCT02995395 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT02995395 end?

The registry lists a primary completion date of 31 Aug 2019 and a study completion date of 31 Aug 2020. The sponsor last updated the record on 3 Feb 2021.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.